Carl Zeiss Meditec (AFX) PT Set at €80.00 by HSBC

Share on StockTwits

Carl Zeiss Meditec (ETR:AFX) received a €80.00 ($93.02) price target from research analysts at HSBC in a note issued to investors on Thursday. The brokerage currently has a “neutral” rating on the stock. HSBC’s price objective indicates a potential downside of 1.54% from the stock’s previous close.

AFX has been the subject of several other reports. Commerzbank set a €58.00 ($67.44) price objective on Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Tuesday, November 27th. Berenberg Bank set a €68.00 ($79.07) price objective on Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Monday. Kepler Capital Markets set a €62.00 ($72.09) price objective on Carl Zeiss Meditec and gave the stock a “sell” rating in a research note on Tuesday, January 15th. Independent Research set a €74.00 ($86.05) price objective on Carl Zeiss Meditec and gave the stock a “sell” rating in a research note on Tuesday, January 22nd. Finally, Hauck & Aufhaeuser set a €69.00 ($80.23) price objective on Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Friday, December 7th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of €72.94 ($84.81).

ETR:AFX opened at €81.25 ($94.48) on Thursday. Carl Zeiss Meditec has a one year low of €37.53 ($43.64) and a one year high of €55.25 ($64.24).

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Read More: How to Use a Moving Average for Trading 

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.